CD22-Binding Peptides Derived from Anti-CD22 Ligand Blocking Antibodies Retain the Targeting and Cell Killing Properties of the Parent Antibodies and May Serve as a Drug Delivery Vehicle
David Pearson, Robert T. O’Donnell, Miguel Cerejo, Hayes C. McKnight, Xiaobing Wang, Jan Mařik, Kit S. Lam, Joseph M. TuscanoVolume:
14
Language:
english
Pages:
10
DOI:
10.1007/s10989-008-9138-z
Date:
September, 2008
File:
PDF, 504 KB
english, 2008